Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lu AA21004 vs mirtazapine vs placebo driving performance crossover study in healthy volunteers
NL-OMON33491Active, not recruiting
- Sponsor
- Lundbeck
- Start
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Crossover sequence including vortioxetine, Crossover sequence including mirtazapine and Crossover sequence including placebo (3 arms). Primary endpoint: Standard deviation of lateral position after vortioxetine versus placebo. Started Jun 2009; status: active, not recruiting.
02
Drugs
vortioxetinemirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON33491.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33491.